U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533422) titled 'Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testin... Read More
Punjab, April 17 -- MUNICH, April 18, 2026 /PRNewswire/ - The largest real-world study of its kind, presented today atESCMID Global 2026, shows that maternal vaccination against respiratory syncytial ... Read More
France, April 17 -- Bestowed by the Roosevelt Foundation, established in 1982, the awards honour the "Four Freedoms" outlined by US President Franklin D. Roosevelt in his 1941 State of the Union addre... Read More
Agartala, April 17 -- The Tipra Motha Party (TMP) registered a landslide victory in the Tripura Tribal Areas Autonomous District Council (TTAADC) elections, securing 24 out of the 28 elective seats, a... Read More
Mumbai, April 17 -- The project involves construction of key bridges under the third and fourth railway line expansion between Nergundi-Barang and Khurda Road-Vizianagaram on the Bhadrak-Vizianagaram ... Read More
India, April 17 -- During Friday's trading session, shares of one of India's leading defence technology companies and a leader in providing advanced defence training and anti-drone solutions, surged n... Read More
India, April 17 -- The Supreme Court of India on Friday declined to vacate its stay on the Telangana High Court's order granting transit anticipatory bail to Congress leader Pawan Khera in a case regi... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 17 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More